Sulphonylureas in pregnancySTEEL, J. M; JOHNSTONE, F. D; TOLMIE, J et al.Lancet (British edition). 1991, Vol 338, Num 8776, issn 0140-6736, p. 1222Article

Variation in TCF7L2 influences therapeutic response to sulfonylureas : A GoDARTs studyPEARSON, Ewan R; DONNELLY, Louise A; KIMBER, Charlotte et al.Diabetes (New York, NY). 2007, Vol 56, Num 8, pp 2178-2182, issn 0012-1797, 5 p.Article

Effect of sulfonylurea agents on pyruvate dehydrogenase activity in circulating lymphocytes from patients with non-insulin-dependent diabetes mellitus (NIDDM)RINAUDO, M. T; CURTO, M; RABBONE, I et al.Journal of diabetes and its complications. 1994, Vol 8, Num 4, pp 221-225, issn 1056-8727Conference Paper

Fun with mutants: applying genetic methods to problems of weed physiologyCHRISTIANSON, M.L.Weed science. 1991, Vol 39, Num 3, pp 489-496, issn 0043-1745Article

Metabolism of sulfometuron-methyl in wheat and its possible role in wheat intoleranceANDERSON, J. J; SWAIN, R. S.Journal of agricultural and food chemistry (Print). 1992, Vol 40, Num 11, pp 2279-2283, issn 0021-8561Article

Recurrent hypoglycemia secondary to drug-dispensing errorSHUMAK, S. L; CORENBLUM, B; STEINER, G et al.Archives of internal medicine (1960). 1991, Vol 151, Num 9, pp 1877-1878, issn 0003-9926Article

Rise of plasma t-PA fibrinolytic activity in a group of maturity onset diabetic patients shifted from a first generation (tolbutamide) to a second generation sulphonylurea (gliclazide)GRAM, J; KOLD, A; JESPERSEN, J et al.Journal of internal medicine. 1989, Vol 225, Num 4, pp 241-247, issn 0954-6820, 7 p.Article

Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: Patient characteristics and initial response to sulfonylurea therapySAGEN, Jørn V; RAEDER, Helge; GLOYN, Anna L et al.Diabetes (New York, NY). 2004, Vol 53, Num 10, pp 2713-2718, issn 0012-1797, 6 p.Article

Potentiation by previous nutrients of glibenclamide-induced insulin release in man. An effect which is counteracted by meal-induced retardation of drug absorptionGRILL, V; EFENDIC, S; REGITZ, G et al.Scandinavian journal of clinical & laboratory investigation. 1986, Vol 46, Num 6, pp 527-532, issn 0036-5513Article

Interactions médicamenteuses et sulfamides hypoglycémiantsGIRARDIN, E; JADOT, G.Lyon Méditerranée médical. Médecine du sud-est. 1991, Vol 27, Num 9-10, pp 637-642, issn 0766-5466Article

Oral hypoglycemic agents : sulfonylureaFARRAR, G. E; SHUMAN, C. R; KROSNICK, A et al.Clinical therapeutics. 1991, Vol 13, Num 2, pp 319-323, issn 0149-2918, 5 p.Article

A mutation in the TMD0-L0 region of sulfonylurea receptor-1 (L225P) causes permanent neonatal diabetes mellitus (PNDM)MASIA, Ricard; DE LEON, Diva D; MACMULLEN, Courtney et al.Diabetes (New York, NY). 2007, Vol 56, Num 5, pp 1357-1362, issn 0012-1797, 6 p.Article

Effects of gliclazide beyond metabolic controlCERIELLO, Antonio.Metabolism, clinical and experimental. 2006, Vol 55, Num 5, issn 0026-0495, S10-S15, SUP1Conference Paper

Peanut (Arachis hypogaea L.) response to residual and in-season treatments of CGA-362622PORTERFIELD, Dunk; WILCUT, John W.Weed technology. 2003, Vol 17, Num 3, pp 441-445, issn 0890-037X, 5 p.Article

Sulfonylureas and related compounds : chemistry and structure-activity relationshipsPLÜMPE, H.Handbook of experimental pharmacology. 1996, Vol 119, pp 65-72, issn 0171-2004Article

Heterozygous ABCC8 mutations are a cause of MODYBOWMAN, P; FLANAGAN, S. E; EDGHILL, E. L et al.Diabetologia (Berlin). 2012, Vol 55, Num 1, pp 123-127, issn 0012-186X, 5 p.Article

Sulfonylurea compounds uncouple the glucose dependence of the insulinotropic effect of glucagon-like peptide 1DE HEER, Jocelyn; HOIST, Jens J.Diabetes (New York, NY). 2007, Vol 56, Num 2, pp 438-443, issn 0012-1797, 6 p.Article

Development and evaluation of glyburide fast dissolving tablets using solid dispersion techniqueVALLERI, M; MURA, P; MAESTRELLI, F et al.Drug development and industrial pharmacy. 2004, Vol 30, Num 5, pp 525-534, issn 0363-9045, 10 p.Article

Differential effects of glucose and glyburide on energetics and Na⁺ levels of βHC9 cells: Nuclear magnetic resonance spectroscopy and respirometry studiesDOLIBA, Nicolai M; VATAMANIUK, Marko Z; BUETTGER, Carol W et al.Diabetes (New York, NY). 2003, Vol 52, Num 2, pp 394-402, issn 0012-1797, 9 p.Article

Factitious hypoglycaemia documented by a modified assay for the measurement of plasma sulphonylureaSENER, A; GILLET, C; VERHELST, J et al.Diabetic medicine. 1995, Vol 12, Num 5, pp 433-435, issn 0742-3071Article

Torsemide : a pyridine-sulfonylurea loop diureticBLOSE, J. S; ADAMS, K. F; PATTERSON, J. H et al.The Annals of pharmacotherapy. 1995, Vol 29, Num 4, pp 396-402, issn 1060-0280Article

The relationship between early insulin release and glucose tolerance in healthy subjectsGROOP, P.-H; MELANDER, A; GROOP, L. C et al.Scandinavian journal of clinical & laboratory investigation. 1993, Vol 53, Num 4, pp 405-409, issn 0036-5513Article

Glucose-stimulated insulin release by individual pancreatic β cells : potentiation by glyburideEGAN, J. M; ASPLIN, C. M; DRUMHELLER, M. A et al.Proceedings of the Society for Experimental Biology and Medicine. 1991, Vol 196, Num 2, pp 203-209, issn 0037-9727Article

Promising herbicides based on sulfonylureasMEL'NIKOV, N. N; ARONOVA, N. I.Soviet chemical industry. 1990, Vol 22, Num 11, pp 1-12, issn 0038-5344Article

Simultaneous determination of the sulphonylurea glimepiride and its metabolites in human serum and urine by high-performance liquid chromatography after pre-column derivatizationLEHR, K. H; DAMM, P.Journal of chromatography. Biomedical applications. 1990, Vol 526, Num 2, pp 497-505, issn 0378-4347Article